Should long-acting beta 2-agonists be considered an alternative first choice option for the treatment of stable COPD?

Respir Med. 1999 Apr;93(4):227-9. doi: 10.1016/s0954-6111(99)90017-3.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adrenergic beta-Agonists / therapeutic use*
  • Cholinergic Antagonists / therapeutic use
  • Humans
  • Lung Diseases, Obstructive / drug therapy*
  • Treatment Outcome

Substances

  • Adrenergic beta-Agonists
  • Cholinergic Antagonists